Tesla's price war is over, says Roth MKM's Craig Irwin
Craig Irwin, Roth MKM senior research analyst, joins 'Money Movers' to discuss Tesla's stock pop following its quarterly ...
MAG Silver cut at Roth MKM as Juanicipio strength seen offset by metals price pullback
MAG Silver (NYSE:MAG) -1% in Thursday's trading as Roth MKM downgrades shares to Neutral from Buy with a $17.50 price target following the production update from the Juanicipio gold-silver mine in ...
bovnews7h
Accuray Inc (ARAY) Stock Rated Buy by ROTH MKM
On Wednesday, Accuray Inc (ARAY) stock saw a decline, ending the day at $1.75 which represents a decrease of $-0.02 or -1.13% from the prior close of $1.77. The stock opened at $1.76 and touched a low ...
Roth MKM is growing concerned about the technology sector
Roth MKM indicated to the investment community that it might be time to start rethinking about the Information Technology ...
Credo Technology Group (NASDAQ:CRDO) Price Target Raised to $45.00 at Roth Mkm
Credo Technology Group (NASDAQ:CRDO – Get Free Report) had its target price boosted by equities researchers at Roth Mkm from ...
Energy Fuels price target raised to $6 from $4.75 at Roth MKM
Roth MKM raised the firm’s price target on Energy Fuels (UUUU) to $6 from $4.75 and keeps a Neutral rating on the shares. The firm has ...
Roth Capital Comments on Celsius’ Q3 Earnings (NASDAQ:CELH)
Research analysts at Roth Capital cut their Q3 2024 EPS estimates for Celsius in a note issued to investors on Monday, ...
bovnews1d
Why Did ROTH MKM Give Coterra Energy Inc (CTRA) Stock Buy Rating?
Notable insider trades include Roemer Todd M, Vice Pres & CAO at Coterra Energy Inc (CTRA), who sold 55000 shares on Mar 20 ’24, at $27.06 each, totaling $1.49 million. On Mar 01 ’24, DeShazer Michael ...
Energy Vault price target raised to $2.50 from $2 at Roth MKM
Roth MKM raised the firm’s price target on Energy Vault (NRGV) to $2.50 from $2 and keeps a Buy rating on the shares after ...
Business Insider1d
Cardiol Therapeutics (CRDL) Gets a Buy from Roth MKM
Roth MKM analyst Jason Wittes maintained a Buy rating on Cardiol Therapeutics (CRDL – Research Report) today and set a price target of $10.00. The company’s shares closed yesterday at $1.87. Wittes ...
This is what really caused the US10Y to rise – analyst
The rise in the US10Y was caused by a re-pricing of the Fed’s rate-cutting path after strong non-farm payrolls in September, said Roth MKM's Michael Darda.
Meta Platforms price target raised to $620 from $550 at Roth MKM
Roth MKM analyst Rohit Kulkarni raised the firm’s price target on Meta Platforms to $620 from $550 and keeps a Buy rating on ...